This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15)
Molecular Cancer Open Access 18 January 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Renneville A, Roumier C, Biggio V, Nibourel O, Boissel N, Fenaux P et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia 2008; 22: 915–931.
Moore MA, Chung KY, Plasilova M, Schuringa JJ, Shieh JH, Zhou P et al. NUP98 dysregulation in myeloid leukemogenesis. Ann N Y Acad Sci 2007; 1106: 114–142.
Ageberg M, Drott K, Olofsson T, Gullberg U, Lindmark A . Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis. Genes Chromosomes Cancer 2008; 47: 276–287.
Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909–1918.
Chou WC, Chen CY, Hou HA, Lin LI, Tang JL, Yao M et al. Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. Leukemia 2009; 23: 1303–1310.
Slape C, Liu LY, Beachy S, Aplan PD . Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl. Blood 2008; 112: 2017–2019.
Virappane P, Gale R, Hills R, Kakkas I, Summers K, Stevens J et al. Mutation of the wilms’ tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 2008; 26: 5429–5435.
Ariyaratana S, Loeb DM . The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis. Expert Rev Mol Med 2007; 9: 1–17.
Acknowledgements
This work was supported by a Grant-in-Aid for Cancer Research, Research on Children and Families, Research on intractable diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan, and by Grants-in-Aid for Scientific Research (B, C) or Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank Drs Ryoji Hanada (Division of Hematology/Oncology, Saitama Children's Medical Center, Japan), Kazuko Hamamoto (Department of Pediatrics, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Japan), Hideo Nakamura (Department of Internal Medicine, Koufudai Hospital, Nagasaki, Japan), Kazuma Ohyashiki (First Department of Internal Medicine, Division of Hematology, Tokyo Medical University, Japan), Ikuo Miura, Department of Internal Medicine (Division of Hematology and Oncology, St Marianna University School of Medicine, Japan), Keiki Kawakami (Division of Hematology, Suzuka General Hospital, Japan), Hiroshi Miwa (Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Japan), Takaharu Matsuyama (Division of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Japan) and Yasuhito Arai, PhD (Cancer Genome Project, National Cancer Center Research Institute, Tokyo, Japan) for providing samples and clinical data of patients with chromosomal 11p15 translocations. We also thank Mrs Shoko Sohma, Hisae Soga, Midori Furui, Mayumi Naito, Mayumi Nagase and Rie Eda for their excellent technical assistance.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Taketani, T., Taki, T., Nakamura, T. et al. High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes. Leukemia 24, 1975–1977 (2010). https://doi.org/10.1038/leu.2010.207
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.207
This article is cited by
-
Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions
International Journal of Hematology (2019)
-
NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis
Leukemia (2017)
-
Identification of MYC mutations in acute myeloid leukemias with NUP98–NSD1 translocations
Leukemia (2016)
-
POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15)
Molecular Cancer (2013)
-
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern
Leukemia (2013)